ArticleMolecular biology reports2026
Nuciferine attenuates uric acid-induced apoptosis in HUVECs via regulation of the SIRT6/ROS signaling pathway.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundNuciferine, a constituent of lotus leaf, has a potentially beneficial effect for cardiovascular disease therapy. Sirtuin6 (SIRT6) is a component of the class III histone deacetylase group that depends on NAD METHODS AND
resultsIn uric acid (UA)-stimulated HUVECs, nuciferine increased cell viability and nitric oxide level. UA increased the apoptosis of HUVECs. Nuciferine inhibited apoptotic cell percentage and Bax/Bcl-2 ratio as well as expression of cleaved caspase-3 protein and caspase-3 activity. Moreover, nuciferine increased the SIRT6 expression in HUVECs exposed to UA. Significantly, the silencing of SIRT6 negated the protective effect of nuciferine on the apoptosis of HUVECs. Additional investigations indicated that nuciferine also reduced the reactive oxygen species (ROS) generation in HUVECs. Furthermore, nuciferine exerted a suppressive impact on HUVECs apoptosis, which was partially mediated by the reduction of ROS.
conclusionsCollectively, our data suggest that nuciferine can regulate the apoptosis in HUVECs, potentially through mechanisms involving SIRT6 and ROS.
Indexed as
Identifiers
42377682What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.